X4 Pharmaceuticals is a BUY, driven by a funded Phase 3 trial, current product pipeline, and a strong cash position extending ...

Discover how a single-purpose reverse mortgage allows older homeowners to convert home equity into cash for specific purposes ...

Positive results from the aleniglipron Phase 2 ACCESS programs in December 2025 demonstrated significant weight loss across all doses and up to ...

Q4 2025 earnings call highlights: obesity WVE-007 data, RNA editing WVE-006 updates, GSK milestones, runway—read now.

The EFC2400 leverages nearly a decade of our experience in customer‑specific natural refrigerant systems and packages ...

Elsco Transformers reports that choosing the right transformer size involves calculating kVA based on voltage and current for efficient operations.

Abstract: With the application of single-phase converter, the single-phase phase-locked loop (PLL) has received widespread attention. In this article, a single-phase self-feedback PLL (SF-PLL) is ...

Full Study Results Expected in Q1 2026 Further Clinical Development of NAV-240 in Hidradenitis Suppurativa to Begin in Early 2026 SCOTCH PLAINS, NJ., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Navigator ...

CINCINNATI--(BUSINESS WIRE)--Edge Energy, a leader in innovative energy solutions, today announced a collaborative next-generation solution with Lincoln Electric that is designed to bring, fast ...

First subject dosed with NAV-240 in multiple-ascending dose study in healthy volunteers Primary objective of Phase 1b study is safety, tolerability, PK and PD of NAV-240 after repeated administration ...